VIRIDIAN Trademark

Trademark Overview

On Wednesday, March 3, 2021, a trademark application was filed for VIRIDIAN with the United States Patent and Trademark Office. The USPTO has given the VIRIDIAN trademark a serial number of 90556932. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by Viridian Therapeutics, Inc.. The VIRIDIAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development services in the field of biotechnology in the nature of immunotherapeutic treatments for autoimmune diseases and immunological disorders
viridian

General Information

Serial Number90556932
Word MarkVIRIDIAN
Filing DateWednesday, March 3, 2021
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7021545
Registration DateTuesday, April 11, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Description of MarkThe mark consists of stylized arrows with the word "VIRIDIAN" to the right.
Goods and ServicesScientific research and development services in the field of biotechnology in the nature of immunotherapeutic treatments for autoimmune diseases and immunological disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 2, 2022
Primary Code042
First Use Anywhere DateTuesday, January 19, 2021
First Use In Commerce DateTuesday, January 19, 2021

Trademark Owner History

Party NameViridian Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameViridian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameViridian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Sunday, September 26, 2021NON-FINAL ACTION E-MAILED
Saturday, March 6, 2021NEW APPLICATION ENTERED
Wednesday, June 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 3, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, September 25, 2021ASSIGNED TO EXAMINER
Sunday, September 26, 2021NON-FINAL ACTION WRITTEN
Sunday, September 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2022FINAL REFUSAL WRITTEN
Tuesday, May 10, 2022FINAL REFUSAL E-MAILED
Tuesday, May 10, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, November 10, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, November 10, 2022EXPARTE APPEAL RECEIVED AT TTAB
Thursday, November 10, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, November 10, 2022EX PARTE APPEAL-INSTITUTED
Thursday, December 15, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 15, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 15, 2022EXAMINER'S AMENDMENT ENTERED
Sunday, December 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 18, 2022EXPARTE APPEAL TERMINATED
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

viridian autoimmune treatments diseases immunological disorders immunotherapeutic nature development research services